Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat and Sargramostim in Myeloid Malignancies
NCT00462605Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2007
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat in myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by National Cancer Institute. Started Apr 2007; status: completed.
02
Drugs
entinostat
03
Conditions
myelodysplastic syndrome (MDS)acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00462605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462605.